Search Results

1 - 10 of 28 items :

  • pharmacokinetics x
  • Microbiology and Virology x
Clear All
Development of a UHPLC-MS/MS method for the determination of quercetin in milk and its application to a pharmacokinetic study

References 1. de Boer V.C., Dihal A.A., van der Woude H., Arts I.C., Wolffram S., Alink G.M., Rietjens I.M., Keijer J., Hollman P.C.: Tissue distribution of quercetin in rats and pigs. J Nutrit 2005, 135, 1718–1725. 2. Chang L., Ren Y., Cao L., Sun Y., Sun Q., Sheng N., Yuan L., Zhi X., Zhang L.: Simultaneous determination and pharmacokinetic study of six flavonoids from Fructus Sophorae extract in rat plasma by LC–MS/MS. J Chrom B 2012, 904, 59–64. 3. Coppin J.P., Xua Y., Chena H., Pan M.H., Hoc Ch.T., Juliani R., Simon J.E., Wu Q

Open access
The progress in study of fosfomycin

, phosphonomycin amino butyl alcohol three salt granules, and fosfomycin two sodium salt for injection. Although the clinical application of phosphomycin has increased in recent years, there are few clinical reports in China. According to the related literatures at home and abroad, this review briefly introduces fosfomycin in the following three aspects: progress in synthetic methods, pharmacokinetic and pharmacodynamic characteristics, and antibacterial activities, to provide references for clinical rational use. 2 The synthesis of fosfomycin Fosfomycin was first

Open access
Withdrawal of amoxicillin and penicillin G procaine from milk after intramammary administration in dairy cows with mastitis

References 1. Bengtsson B., Jacobsson S.O., Luthman J., Franklin A.: Pharmacokinetics of penicillin-G in ewes and cows in late pregnancy and in early lactation. J Vet Pharmacol Ther 1997, 20, 258–261. 2. Błądek T, Posyniak A, Gajda A, Gbylik M, Żmudzki J.: Multi-class procedure for analysis of antibacterial compounds in animal tissues by liquid chromatography tandem mass spectrometry. Bull Vet Inst Pulawy 2011, 55, 741–748. 3. Bruno F., Curini R., di Corcia A., Nazzari M., Samperi R.: Solid-phase extraction followed by liquid chromatography

Open access
Pharmacokinetic - pharmacodynamic model and ampicillin residue depletion after intramammary administration in cows

., Marosevic D., Jaglic Z.: Prevalence of mastitis pathogens in milk from clinically healthy cows. Med Weter 2013, 58, 567–575. 4. Christensen J.M., Smith B.B., Murdena S.B., Hollingshead N.: The disposition of five therapeutically important antimicrobial agents in llamas. J Vet Pharmacol Ther 1996, 19, 43–438. 5. Concordet D., Toutain P.L.: The withdrawal time estimation of veterinary drugs revisited. J Vet Pharmacol Ther 1997, 20, 380–386. 6. Craigmill A.L., Pass M.A., Wetzlich S.: Comparative pharmacokinetics of AMX administered intravenously to sheep

Open access
Analytical Procedure for the Determination of Tulathromycin in Swine Plasma

References 1. Anon. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine: Guidance for Industry, Bioanalytical Method Validation, 2001. 2. Anon. European Medicines Agency (EMEA): Guideline on bioanalytical method validation, 2011. 3. Benchaoui H.A., Nowakowski M., Sherington J., Rowan T.G., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol

Open access
LC-MS/MS analysis of doxycycline residues in chicken tissues after oral administration

1998, 708, 145-152. 9. Dorrestein G.M., Bruijne J.J.D., Vulto A.: Bioavailability of doxycycline injectable in pigeons. Acta Vet Scand Suppl 1991, 87, 291-292. 10. El-Gendi A.Y.I., Atef M., Amer A.M.M., Kamel G.M.: Pharmacokinetics and tissue distribution of doxycycline in broiler chickens pretreated with either: Diclazuril or halofuginone. Food Chem Toxicology 2010, 48, 3209-3214. 11. EMEA Summary Report Doxycycline (2), European Medicines Agency Veterinary Medicines and Inspections, Committee for Veterinary Medicinal

Open access
Effect of doxycycline concentrations in chicken tissues as a consequence of permanent exposure to enrofloxacin traces in drinking water

1982, 4, 115–135. 10. De Ruyck H., De Ridder H., Van Renterghem R., Van Wambeke F.: Validation of HPLC method of analysis of tetracycline residues in eggs and broiler meat and its application to a feeding trial. Food Addit Contam Part A 1999, 16, 47–56. 11. El-Gendi A.Y., Atef M., Amer A.M., Kamel G.M.: Pharmacokinetic and tissue distribution of doxycycline in broiler chickens pretreated with either: diclazuril or halofuginon. Food Chem Toxicol 2010, 48, 3209–3214. 12. Ershov E., Bellaiche M., Hanji V., Soback S., Gips M., Shlosberg A.: Interaction

Open access
Comparison of albendazole cytotoxicity in terms of metabolite formation in four model systems

non-clinical toxicity and pharmacokinetics. Acta Trop 2003, 86, 141-159. 10. Delatour P., Benoit E., Besse S., Boukraa A.: Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs, and rats. Xenobiotica 1991, 21, 217-221. 11. Delatour P., Benoit E., Caude M., Tambute A.: Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats. Chirality 1990, 2, 156-160. 12. Delatour P.: Some aspects of the teratogenicity of veterinary drugs. Vet Res Commun 1983

Open access
Effects of Tetracycline on Ruminal Activity and Blood Calcium in Sheep

REFERENCES 1. Agwuh, K. N., MacGowan, A., 2006: Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemotherapy , 58, 256—265. 2. Attebery, J. T., Johnson, H. D., 1969: Effects of environmental temperature, controlled feeding and fasting on rumen motility. J. Anim. Sci. , 29, 734—737. 3. Bengtsson, B., Franklin, A., Luthman, J., Jacobsson, S. O., 1989: Concentrations of sulphadimidine, oxytetracycline and penicillin G in serum, synovial fluid and tissue cage fluid after parenteral

Open access
Successful Treatment with Triple Therapy of Amphotericin B, Voriconazole and Flucytosine on an AIDS Patients with Severe Cryptococcal Meningitis

. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. J Antimicrob Chemother 2007;60:162-165. 4 Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 2005;43: 2163-2167. 5 Liu P, Foster G, LaBadie RR, Gutierrez MJ, Sharma A. Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects. J Clin Pharmacol 2008;48:73-84. 6

Open access